These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9926859)

  • 1. Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats.
    Joo WS; Jin BK; Park CW; Maeng SH; Kim YS
    Neuroreport; 1998 Dec; 9(18):4123-6. PubMed ID: 9926859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system.
    Kim YS; Joo WS; Jin BK; Cho YH; Baik HH; Park CW
    Neuroreport; 1998 Jul; 9(10):2387-90. PubMed ID: 9694233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease.
    Lin L; Meng T; Liu T; Zheng Z
    Life Sci; 2013 Mar; 92(4-5):311-6. PubMed ID: 23333823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered melatonin MT
    Kang NH; Carriere CH; Bahna SG; Niles LP
    Brain Res; 2016 Dec; 1652():89-96. PubMed ID: 27693415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
    Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
    Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endogenous melatonin on glutamate and GABA rhythms in the striatum of unilateral 6-hydroxydopamine-lesioned rats.
    Meng T; Yuan S; Zheng Z; Liu T; Lin L
    Neuroscience; 2015 Feb; 286():308-15. PubMed ID: 25499317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study.
    Wąsik A; Romańska I; Zelek-Molik A; Antkiewicz-Michaluk L
    Neurotox Res; 2018 Apr; 33(3):523-531. PubMed ID: 29076060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine differentiation factors increase striatal dopaminergic function in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mice.
    Jin BK; Iacovitti L
    J Neurosci Res; 1996 Feb; 43(3):331-4. PubMed ID: 8714521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D protects dopaminergic neurons against neuroinflammation and oxidative stress in hemiparkinsonian rats.
    Lima LAR; Lopes MJP; Costa RO; Lima FAV; Neves KRT; Calou IBF; Andrade GM; Viana GSB
    J Neuroinflammation; 2018 Aug; 15(1):249. PubMed ID: 30170624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals.
    Snyder GL; Keller RW; Zigmond MJ
    J Pharmacol Exp Ther; 1990 May; 253(2):867-76. PubMed ID: 2110978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D (VD3) Intensifies the Effects of Exercise and Prevents Alterations of Behavior, Brain Oxidative Stress, and Neuroinflammation, in Hemiparkinsonian Rats.
    da Costa RO; Gadelha-Filho CVJ; de Aquino PEA; Lima LAR; de Lucena JD; Ribeiro WLC; Lima FAV; Neves KRT; de Barros Viana GS
    Neurochem Res; 2023 Jan; 48(1):142-160. PubMed ID: 36028736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
    Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
    J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.
    Jin BK; Shin DY; Jeong MY; Gwag MR; Baik HW; Yoon KS; Cho YH; Joo WS; Kim YS; Baik HH
    Neurosci Lett; 1998 Apr; 245(2):61-4. PubMed ID: 9605485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
    Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
    Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine.
    Dluzen D
    Brain Res; 1997 Sep; 767(2):340-4. PubMed ID: 9367266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-DOPA modulation of corpus striatal dopamine and dihydroxyphenylacetic acid output from intact and 6-OHDA lesioned rats.
    Xu K; Dluzen DE
    J Neural Transm (Vienna); 1996; 103(11):1295-305. PubMed ID: 9013416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.